Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02276040 · ClinicalTrials.gov registry record
Serum Levels of Bupivacaine in Autotransfusion Drains Following Total Joint Arthroplasty
A clinical trial, sponsored by OrthoCarolina Research Institute.
- Completed
- Registry status
- 26
- Enrollment target
NCT02276040 is a clinical trial that has completed, run by OrthoCarolina Research Institute. The registered enrollment target is 26 participants.
The verdict
NCT02276040 has completed, sponsored by OrthoCarolina Research Institute.
- COMPLETED
- Registry status
- 26 participants
- Enrollment target
Study Summary
The purpose of this study is to quantify the total blood serum levels of bupivacaine in OrthoPAT® collected blood 2 hours and 5 hours postoperatively. Hypothesis: Filtered blood from the OrthoPAT® autotransfusion system contains low or undetectable levels of bupivacaine hydrochloride (HCL). Reinfusion of collected blood from the OrthoPAT® device when used in conjunction with periarticular bupivicaine injections will not pose a bupivocaine toxicity risk to patients undergoing a total joint arthroplasty.
Interventions
- DRUG periarticular bupivicaine and liposomal bupivicaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2014-10 |
| Est. Completion | 2017-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02276040
The ClinicalTrials.gov registry entry for NCT02276040 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is OrthoCarolina Research Institute, which has 28 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which periarticular bupivicaine and liposomal bupivicaine is the first listed.
NCT02276040 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02276040 about?
NCT02276040 is a clinical study titled "Serum Levels of Bupivacaine in Autotransfusion Drains Following Total Joint Arthroplasty". The purpose of this study is to quantify the total blood serum levels of bupivacaine in OrthoPAT® collected blood 2 hours and 5 hours postoperatively. Hypothesis: Filtered blood from the OrthoPAT® autotransfusion system contains low or undetectable levels of bupivacaine hydrochloride (HCL). Reinfus...
What is the current status of trial NCT02276040?
This trial is currently completed. The enrollment target is 26 participants. The study started on 2014-10. Estimated completion is 2017-06-30.
What interventions are being tested in trial NCT02276040?
The interventions under investigation include: periarticular bupivicaine and liposomal bupivicaine (DRUG).
Who is sponsoring clinical trial NCT02276040?
This trial is sponsored by OrthoCarolina Research Institute, which has 28 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.